Abstract:Background/Objectives: Breast cancer in women is the most commonly diagnosed and most malignant tumor. Although luminal A breast cancer (LumA) has a relatively better prognosis, it still has a persistent pattern of recurrence. Ganoderma lucidum (Curtis) P. Karst. is a kind of traditional Chinese medicine and has antitumor effects. In this study, we aimed to identify the genes relevant to prognosis, find novel targets, and investigate the function of the bioactive protein from G. lucidum, called FIP-glu, in improving prognosis. Methods: Gene expression data and clinical information of LumA breast cancer patients were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Using bioinformatics methods, a predictive risk model was constructed to predict the prognosis for each patient. The cell counting kit-8 (CCK8) and clone formation assays were used to validate gene function. The ability of FIP-glu to regulate RNA levels of risk genes was validated. Results: Six risk genes (slit-roundabout GTPase-activating protein 2 (SRGAP2), solute carrier family 35 member 2 (SLC35A2), sequence similarity 114 member A1 (FAM114A1), tumor protein P53-inducible protein 11 (TP53I11), transmembrane protein 63C (TMEM63C), and polymeric immunoglobulin receptor (PIGR)) were identified, and a prognostic model was constructed. The prognosis was worse in the high-risk group and better in the low-risk group. The receiver operating characteristic (ROC) curve confirmed the model's accuracy. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses showed that the differentially expressed genes (DEGs) between the high- and low-risk groups were significantly enriched in the immune responses. TMEM63C could promote tumor viability, growth, and proliferation in vitro. FIP-glu significantly regulated these risk genes, and attenuated the promoting effect of TMEM63C in breast cancer cells. Conclusions: SRGAP2, SLC35A2, FAM114A1, TP53I11, TMEM63C, and PIGR were identified as the potential risk genes for predicting the prognosis of patients. TMEM63C could be a potential novel therapeutic target. Moreover, FIP-glu was a promising drug for improving the prognosis of LumA breast cancer.

Ganoderma immunomodulatory proteins: mushrooming functional FIPs

Identification a novel Ganoderma FIP gene from Ganoderma capense and its functional expression in Pichia pastoris

Production and Functional Characterization of a Novel Fungal Immunomodulatory Protein FIP-SN15 Shuffled from Two Genes of Ganoderma Species.

Recombinant Expression and Bioactivity Comparison of Four Typical Fungal Immunomodulatory Proteins from Three Main Ganoderma Species

Molecular cloning and recombinant expression of a gene encoding a fungal immunomodulatory protein from Ganoderma lucidum in Pichia pastoris

Immunomodulatory activity of Ganoderma lucidum immunomodulatory protein via PI3K/Akt and MAPK signaling pathways in macrophage RAW264.7 cells

Expression Of Ganoderma Lucidum Fungal Immunomodulatory Protein (Fip-Glu) In Saccharomyces Cerevisiae And Its Immunoreactivity

Characterization, Recombinant Production, and Bioactivity of a Novel Immunomodulatory Protein from Hypsizygus Marmoreus.

Immunomodulatory activity of Ganoderma lucidum immunomodulatory protein via PI3K/Akt and MAPK signaling pathways in RAW264.7 cells.

Genomic Data Mining Approaches for the Discovery of Anticancer Peptides from Ganoderma Sinense.

Genomic Cloning and Characterization of a FIP-gsi Gene Encoding a Fungal Immunomodulatory Protein from Ganoderma Sinense Zhao Et Al. (Aphyllophoromycetideae)

In Vitro Synthesis Of A Recombinant Fungal Immunomodulatory Protein From Lingzhi Or Reishi Medicinal Mushroom, Ganoderma Lucidum (W.Curt.:Fr.) P.Karst. (Aphyllophoromycetideae) And Analysis Of Its Immunomodulatory Activity

Cytokines Expression Induced by Ganoderma sinensis Fungal Immunomodulatory Proteins (FIP-gsi) in Mouse Spleen Cells

Discovery and Characterization of the Highly Active Fungal Immunomodulatory Protein Fip-vvo82.

Functional Expression of FIP-fve, a Fungal Immunomodulatory Protein from the Edible Mushroom Flammulina Velutipes in Pichia Pastoris GS115.

Identification of a Novel Anti-cancer Protein, FIP-bbo, from Botryobasidium Botryosum and Protein Structure Analysis Using Molecular Dynamic Simulation

Ganoderma lucidum (Curtis) P. Karst. Immunomodulatory Protein Has the Potential to Improve the Prognosis of Breast Cancer Through the Regulation of Key Prognosis-Related Genes

Identification And Functional Characterization Of A Novel Immunomodulatory Protein From Morchella Conica Sh

Fungal Proteinaceous Compounds with Multiple Biological Activities

Computational Insights into the Molecular Mechanism of the High Immunomodulatory Activity of LZ-8 Protein Isolated from the Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes).

Gene cloning and recombinant expression of a novel fungal immunomodulatory protein from Trametes versicolor.